Repligen to Participate in 15th Annual Craig-Hallum Institutional Investor Conference
WALTHAM, Mass., May 17, 2018 (GLOBE NEWSWIRE) - Repligen Corporation (NASDAQ:RGEN), a leading life sciences company focused on bioprocessing technology leadership, today announced that Jon K. Snodgres, Chief Financial Officer, will participate in the 15 th Annual Craig-Hallum Institutional Investor Conference, being held on May 30 th in Minneapolis.
The conference is a series of one-on-one meetings with investors and does not include a formal presentation. An updated investor presentation can be accessed on the event date by visiting the Investor Relations section of the Repligen Corporation website at www.repligen.com.
About Repligen Corporation
Repligen Corporation (NASDAQ:RGEN) is a global bioprocessing company that develops and commercializes highly innovative products that deliver cost and process efficiencies to biological drug manufacturers worldwide. Our portfolio includes Protein products (Protein A affinity ligands, cell culture growth